SGS Clinical Pharmacology Unit (CPU) is one of the leading Phase I Units in Europe, conducting complex an innovative Phase I -IIa clinical trials, in healthy subjects and as well as in different patient populations.
We have an extensive track record in designing and performing early clinical development studies, challenging the scope of trials to include safety and pharmacokinetic data, but also pharmacodynamic and efficacy data. Our experienced team manages all technical complexities relating to sampling, laboratory, nursing, medical and pharmacy (including GMP).
In combination with an electronic data source system, we manage fast study start-ups and trial executions in a safe, innovative and sustainable environment, utilizing our continuously growing database of volunteers to ensure a fluent and selective high recruitment capacity.
Our state-of-the art CPU in Antwerp, Belgium, has a 110-bed capacity. It provides a broad range of options, from wards in a hotel-like setting to two to eight-person bedrooms with access to spacious living and relaxation areas. Our CPU’s unique design allows specialty approaches, such as patient trials involving more invasive examinations or controlled testing of infection models. An eight-bed high-care room is available for close safety monitoring during first-in-human testing of new medications. In addition, our technical capabilities are supported by a premium GMP production facility, a centrally located laboratory to facilitate complex sample processing and use of the latest bed-side monitoring and telemetry.
